These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23768781)

  • 1. The effect of cationic albumin-conjugated PEGylated tanshinone IIA nanoparticles on neuronal signal pathways and neuroprotection in cerebral ischemia.
    Liu X; Ye M; An C; Pan L; Ji L
    Biomaterials; 2013 Sep; 34(28):6893-905. PubMed ID: 23768781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of cationic bovine serum albumin-conjugated PEGylated tanshinone IIA nanoparticles on cerebral ischemia.
    Liu X; An C; Jin P; Liu X; Wang L
    Biomaterials; 2013 Jan; 34(3):817-30. PubMed ID: 23111336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of surface charge in targeting pegylated nanoparticles of sulpiride to the brain.
    Parikh T; Bommana MM; Squillante E
    Eur J Pharm Biopharm; 2010 Mar; 74(3):442-50. PubMed ID: 19941957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle.
    Lu W; Wan J; She Z; Jiang X
    J Control Release; 2007 Mar; 118(1):38-53. PubMed ID: 17240471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain delivery and systemic effect of cationic albumin conjugated PLGA nanoparticles.
    Xu F; Lu W; Wu H; Fan L; Gao X; Jiang X
    J Drug Target; 2009 Jul; 17(6):423-34. PubMed ID: 19527113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier.
    Lu W; Tan YZ; Hu KL; Jiang XG
    Int J Pharm; 2005 May; 295(1-2):247-60. PubMed ID: 15848009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of cationic albumin conjugated pegylated nanoparticles holding NC-1900, a vasopressin fragment analog, in memory deficits induced by scopolamine in mice.
    Xie YL; Lu W; Jiang XG
    Behav Brain Res; 2006 Oct; 173(1):76-84. PubMed ID: 16828890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery.
    Lu W; Zhang Y; Tan YZ; Hu KL; Jiang XG; Fu SK
    J Control Release; 2005 Oct; 107(3):428-48. PubMed ID: 16176844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-nociceptive effects of Tanshinone IIA (TIIA) in a rat model of complete Freund's adjuvant (CFA)-induced inflammatory pain.
    Sun S; Yin Y; Yin X; Cao F; Luo D; Zhang T; Li Y; Ni L
    Brain Res Bull; 2012 Sep; 88(6):581-8. PubMed ID: 22705002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The protective effect of polyethylene glycol-conjugated urokinase nanogels in rat models of ischemic stroke when administrated outside the usual time window.
    Cui W; Liu R; Jin H; Huang Y; Liu W; He M
    Biochem Biophys Res Commun; 2020 Mar; 523(4):887-893. PubMed ID: 31955887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-targeting delivery for RNAi neuroprotection against cerebral ischemia reperfusion injury.
    An S; Kuang Y; Shen T; Li J; Ma H; Guo Y; He X; Jiang C
    Biomaterials; 2013 Nov; 34(35):8949-59. PubMed ID: 23968852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tanshinone IIA suppresses lung injury and apoptosis, and modulates protein kinase B and extracellular signal-regulated protein kinase pathways in rats challenged with seawater exposure.
    Li JH; Xu M; Xie XY; Fan QX; Mu DG; Zhang Y; Cao FL; Wang YX; Zhao PT; Zhang B; Jin FG; Li ZC
    Clin Exp Pharmacol Physiol; 2011 Apr; 38(4):269-77. PubMed ID: 21314841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tanshinone IIA, a major component of Salvia milthorriza Bunge, inhibits platelet activation via Erk-2 signaling pathway.
    Maione F; De Feo V; Caiazzo E; De Martino L; Cicala C; Mascolo N
    J Ethnopharmacol; 2014 Sep; 155(2):1236-42. PubMed ID: 25038434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular delivery mechanism and brain delivery kinetics of biodegradable cationic bovine serum albumin-conjugated polymersomes.
    Pang Z; Gao H; Chen J; Shen S; Zhang B; Ren J; Guo L; Qian Y; Jiang X; Mei H
    Int J Nanomedicine; 2012; 7():3421-32. PubMed ID: 22848168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Baicalin-loaded PEGylated cationic solid lipid nanoparticles modified by OX26 antibody on regulating the levels of baicalin and amino acids during cerebral ischemia-reperfusion in rats.
    Liu Z; Zhang L; He Q; Liu X; Okeke CI; Tong L; Guo L; Yang H; Zhang Q; Zhao H; Gu X
    Int J Pharm; 2015 Jul; 489(1-2):131-8. PubMed ID: 25895718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on regulation of tanshinone II(A) on GFAP and ATPase and PDI of cerebral ischemia reperfusion injury in rats].
    Wen PY; Yang FZ; Wang F; Li WW; Zhou L; Huang LH; Zhou J
    Zhong Yao Cai; 2012 Oct; 35(10):1628-32. PubMed ID: 23627131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transferrin-conjugated nanoparticles of poly(lactide)-D-alpha-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier.
    Gan CW; Feng SS
    Biomaterials; 2010 Oct; 31(30):7748-57. PubMed ID: 20673685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effects of tanshinone IIA and/or tetramethylpyrazine in cerebral ischemic injury in vivo and in vitro.
    Tang Q; Han R; Xiao H; Shen J; Luo Q; Li J
    Brain Res; 2012 Dec; 1488():81-91. PubMed ID: 23063715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved biological half-life and anti-tumor activity of TNF-related apoptosis-inducing ligand (TRAIL) using PEG-exposed nanoparticles.
    Lim SM; Kim TH; Jiang HH; Park CW; Lee S; Chen X; Lee KC
    Biomaterials; 2011 May; 32(13):3538-46. PubMed ID: 21306770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotection of early and short-time applying atorvastatin in the acute phase of cerebral ischemia: down-regulated 12/15-LOX, p38MAPK and cPLA2 expression, ameliorated BBB permeability.
    Cui L; Zhang X; Yang R; Wang L; Liu L; Li M; Du W
    Brain Res; 2010 Apr; 1325():164-73. PubMed ID: 20167207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.